Parthasarathy Seshacharyulu
University of Nebraska Medical Center
H-index: 31
North America-United States
Top articles of Parthasarathy Seshacharyulu
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Connectivity mapping-based identification of pharmacological inhibitor targeting HDAC6 in aggressive pancreatic ductal adenocarcinoma | npj Precision Oncology | Pranita Atri Ashu Shah Gopalakrishnan Natarajan Satyanarayana Rachagani Sanchita Rauth | 2024/3/7 |
Understanding the role of Pax5 in development of taxane-resistant neuroendocrine like prostate cancers | Samikshan Dutta Sreyashi Bhattacharya Hanna Harris Ridwan Islam Sanika Bodas | 2023/12/11 | |
ASPORIN: A root of the matter in tumors and their host environment | Shobhit P Lall Zahraa W Alsafwani Surinder K Batra Parthasarathy Seshacharyulu | 2023/11/24 | |
Targeting the EGFR signaling pathway in cancer therapy: What’s new in 2023? | Sushanta Halder Soumi Basu Shobhit P Lall Apar K Ganti Surinder K Batra | 2023/5/4 | |
Targeting LIFR/c-Myc Axis to Overcome Docetaxel Resistance in Prostate Cancer | Cancer Research | Sushanta Halder Sakthivel Muniyan Ramakanth Chirravuri-Venkata Rama Krishna Nimmakayala Palanisamy Nallasamy | 2023/4/4 |
MUC16 promotes triple-negative breast cancer lung metastasis by modulating RNA-binding protein ELAVL1/HUR | Breast Cancer Research | Sanjib Chaudhary Muthamil Iniyan Appadurai Shailendra Kumar Maurya Palanisamy Nallasamy Saravanakumar Marimuthu | 2023/3/14 |
Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia | Jawed Akhtar Siddiqui Ramesh Pothuraju Parvez Khan Gunjan Sharma Sakthivel Muniyan | 2022/4/1 | |
Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic ductal adenocarcinoma | Cancer letters | Chunmeng Zhang Pranita Atri Palanisamy Nallasamy Seema Parte Sanchita Rauth | 2022/12/28 |
The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells | Neoplasia | Chitra Palanivel Neha Chaudhary Parthasarathy Seshacharyulu Jesse L Cox Ying Yan | 2022/3/1 |
Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma | Oncogene | Imayavaramban Lakshmanan Saravanakumar Marimuthu Sanjib Chaudhary Parthasarathy Seshacharyulu Satyanarayana Rachagani | 2022/11/25 |
GDF15 promotes prostate cancer bone metastasis and colonization through osteoblastic CCL2 and RANKL activation | Bone research | Jawed Akhtar Siddiqui Parthasarathy Seshacharyulu Sakthivel Muniyan Ramesh Pothuraju Parvez Khan | 2022/1/20 |
The Pleiotropic role, functions and targeted therapies of LIF/LIFR axis in cancer: Old spectacles with new insights | Sushanta Halder Seema Parte Prakash Kshirsagar Sakthivel Muniyan Hareesh B Nair | 2022/7/1 | |
Reduction in O-glycome induces differentially glycosylated CD44 to promote stemness and metastasis in pancreatic cancer | Oncogene | Frank Leon Parthasarathy Seshacharyulu Rama K Nimmakayala Seema Chugh Saswati Karmakar | 2022/1/3 |
DNA-gold nanoprobe-based integrated biosensing technology for non-invasive liquid biopsy of serum miRNA: A new frontier in prostate cancer diagnosis | Nanomedicine: Nanotechnology, Biology and Medicine | Prakash Kshirsagar Parthasarathy Seshacharyulu Sakthivel Muniyan Satyanarayan Rachagani Lynette M Smith | 2022/7/1 |
Macrophage inhibitory cytokine-1 in cancer: Beyond the cellular phenotype | Sakthivel Muniyan Ramesh Pothuraju Parthasarathy Seshacharyulu Surinder K Batra | 2022/6/28 | |
Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and immunosuppressive signalling | EBioMedicine | Parthasarathy Seshacharyulu Sushanta Halder Ramakrishna Nimmakayala Satyanarayana Rachagani Sanjib Chaudhary | 2022/1/1 |
Regulation and Targeting of MUCINS in Pancreatic Cancer | Shailendra K Gautam Abhijit Aithal Grish C Varshney Parthasarathy Seshacharyulu | 2021/3/21 | |
Differential gene expression-based connectivity mapping identified novel drug candidate and improved Temozolomide efficacy for Glioblastoma | Journal of Experimental & Clinical Cancer Research | Raghupathy Vengoji Pranita Atri Muzafar A Macha Parthasarathy Seshacharyulu Naveenkumar Perumal | 2021/12 |
Nanoscale platform for delivery of active IRINOX to combat pancreatic cancer | Journal of controlled release | Fan Lei Xinyuan Xi Satyanarayana Rachagani Parthasarathy Seshacharyulu Geoffrey A Talmon | 2021/2/10 |
SUMO modification of PAF1/PD2 enables PML interaction and promotes radiation resistance in pancreatic ductal adenocarcinoma | Molecular and cellular biology | Sanchita Rauth Saswati Karmakar Ashu Shah Parthasarathy Seshacharyulu Rama Krishna Nimmakayala | 2021/12/1 |
Co-Authors
